Hydrogel-antimicrobial Peptide Association: A Novel and Promising Strategy to Combat Resistant Infections

M Guerrero, AN Ayala, D Rafael, F Andrade… - Colloids and Surfaces B …, 2024 - Elsevier
Infections from multi-drug resistant bacteria (MDRB) have raised a worldwide concern, with
projections indicating that fatalities from these infections could surpass those from cancer by …

Metabolomics revealed mechanism for the synergistic effect of sulbactam, polymyxin-B and amikacin combination against Acinetobacter baumannii

S Zhu, J Yue, X Wang, J Zhang, M Yu, Y Zhan… - Frontiers in …, 2023 - frontiersin.org
Introduction The emergence of multidrug-resistant (MDR) Acinetobacter baumannii prompts
clinicians to consider treating these infections with polymyxin combination. Methods …

Prediction of tissue exposures of polymyxin-B, amikacin and sulbactam using physiologically-based pharmacokinetic modeling

M Wu, K Feng, X Wu, C Liu, S Zhu, FS Martins… - Frontiers in …, 2024 - frontiersin.org
Background The combination antimicrobial therapy consisting of amikacin, polymyxin-B, and
sulbactam demonstrated in vitro synergy against multi-drug resistant Acinetobacter …

[PDF][PDF] Molecular epidemiology and clinical significance of carbapenemase genes among carbapenem-resistant Acinetobacter baumannii isolates in southern Poland

PA Serwacki, DA Hareza, A Kujawska… - Polish Archives of …, 2024 - researchgate.net
Introduction: The complex interplay between Acinetobacter spp., patients, and the
environment has made it increasingly difficult to optimally treat patients infected with …

Возможности антибактериальной терапии инфекций, вызванных карбапенемоустойчивыми Acinetobacter baumannii

АР Гончарова, ВВ Гостев… - Антибиотики и …, 2024 - antibiotics-chemotherapy.ru
Аннотация В обзоре представлены актуальные схемы терапии инфекций,
ассоциированных с карбапенем-устойчивыми Acinetobacter baumannii, являющимися …

Drug-drug interactions of the reserve antibiotics: A narrative review

CB Božić, M Labović, M Kukurić… - Medicinska …, 2024 - scindeks.ceon.rs
Drug interactions often cause side effects, especially in children, elderly and/or patients with
chronic diseases. Antibiotics are among the most commonly used drugs, so potential impact …

Lek-lek interakcije rezervnih antibiotika: narativna revija

BB Cvijan, M Labović, M Kukurić… - Medicinska …, 2024 - aseestant.ceon.rs
Sažetak Interakcije lekova su veoma česti razlog za pojavu neželjenih efekata naročito kod
dece, starijihi/ili pacijenata sa hroničnim oboljenjima. S obzirom da su antibiotici najčešće …